Pharma Plus SRL
4.1 FTEThe score of Pharma Plus shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -20 % Total assets -22 % Headcount (avg FTE) -27 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharma Plus's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 12 May 2026
- Year ended 31 Dec 2024filed on 17 Jun 2025
- Year ended 31 Dec 2023filed on 12 Jun 2024
- Year ended 31 Dec 2022filed on 09 Jun 2023
- Year ended 31 Dec 2021filed on 07 Jun 2022
Pharma Plus's financial analysis
- Solvency85.2%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharma Plus
Pharma Plus's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0432.850.028
- VAT number
- BE0432850028
- Peppol
- Registered · 0208:0432850028 · as of 07 Nov 2026
- Legal form
- SRL
- Incorporated
- 21 Dec 1987
- Registered office
- 7300 Boussu
- Size
- Micro · 4.1 FTE
- Latest accounts
- 2025 · filed on 12 May 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Pharma Plus (SRL) has been based in Boussu since 1987, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 15,884 € and equity of 876,038 €; its revenue is not published. With 4.1 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 85.2%, above the median of its sector (41.5%).
Companies similar to Pharma Plus
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie DE Neef - Duez Retail sale of pharmaceutical products Mons · balance sheet 181,026 €
- PharmaLEDA Retail sale of pharmaceutical products Ixelles · balance sheet €1.01m
- Verhaeghe Pharma Retail sale of pharmaceutical products Izegem · balance sheet €1.05m
- G-PAS Holding Retail sale of pharmaceutical products Brasschaat · balance sheet 992,375 €
- Pharmadvance Retail sale of pharmaceutical products Chièvres · balance sheet €1.07m
- D'Haen Pharma Retail sale of pharmaceutical products Zottegem · balance sheet 987,565 €
- Demuphar Retail sale of pharmaceutical products Ghent · balance sheet 978,525 €
- Van Geem Retail sale of pharmaceutical products Antwerp · balance sheet €1.08m
Frequently asked questions about Pharma Plus
What is the revenue of Pharma Plus?
Pharma Plus files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pharma Plus?
In Belgium, the VAT number is the company number prefixed with BE: BE0432850028 for Pharma Plus, if the company is VAT-registered. Its company number (CBE) is 0432.850.028.
Where is the registered office of Pharma Plus?
According to the CBE register, the registered office of Pharma Plus is in 7300 Boussu.
What is the equity of Pharma Plus?
At the close of the 2025 financial year, the equity of Pharma Plus amounts to 876,038 €, a solvency of 85.2% of total assets.
How many people work at Pharma Plus?
4.1 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Pharma Plus?
The register lists 5 active mandates at Pharma Plus. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pharma Plus
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →